104 related articles for article (PubMed ID: 38769916)
1. Dosimetric and NTCP analyses for selecting parotid gland cancer patients for proton therapy.
Camarda AM; Vincini MG; Russo S; Comi S; Emiro F; Bazani A; Ingargiola R; Vischioni B; Vecchi C; Volpe S; Orecchia R; Jereczek-Fossa BA; Orlandi E; Alterio D
Tumori; 2024 May; ():3008916241252544. PubMed ID: 38769916
[TBL] [Abstract][Full Text] [Related]
2. Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses.
Dutz A; Lühr A; Troost EGC; Agolli L; Bütof R; Valentini C; Baumann M; Vermeren X; Geismar D; Timmermann B; Krause M; Löck S
Radiother Oncol; 2021 Jul; 160():69-77. PubMed ID: 33872640
[TBL] [Abstract][Full Text] [Related]
3. Normal tissue complication probability modeling to guide individual treatment planning in pediatric cranial proton and photon radiotherapy.
Dell'Oro M; Wilson P; Short M; Hua CH; Merchant TE; Bezak E
Med Phys; 2022 Jan; 49(1):742-755. PubMed ID: 34796509
[TBL] [Abstract][Full Text] [Related]
4. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
[TBL] [Abstract][Full Text] [Related]
5. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
[TBL] [Abstract][Full Text] [Related]
6. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
[No Abstract] [Full Text] [Related]
8. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies.
Liu C; Bhangoo RS; Sio TT; Yu NY; Shan J; Chiang JS; Ding JX; Rule WG; Korte S; Lara P; Ding X; Bues M; Hu Y; DeWees T; Ashman JB; Liu W
J Appl Clin Med Phys; 2019 Jul; 20(7):15-27. PubMed ID: 31112371
[TBL] [Abstract][Full Text] [Related]
9. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
Rana S; Greco K; Samuel EJJ; Bennouna J
J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric Comparison of Intensity-Modulated Radiation Therapy (IMRT) and Intensity-Modulated Proton Therapy (IMPT) for a Novel Oral Tongue Avoidance Concept in Low-Risk Squamous Cell Carcinoma of the Oral Tongue.
Press RH; Hu L; Huang S; Hasan S; Choi JI; Simone CB; Chhabra AM; Gelblum DY; Kabarriti R; Bakst RL; Cracchiolo JR; McBride SM; Lee NY
Int J Part Ther; 2023; 9(4):253-260. PubMed ID: 37169010
[TBL] [Abstract][Full Text] [Related]
11. Dose-Volume and Radiobiological Model-Based Comparative Evaluation of the Gastrointestinal Toxicity Risk of Photon and Proton Irradiation Plans in Localized Pancreatic Cancer Without Distant Metastasis.
Raturi VP; Tochinai T; Hojo H; Rachi T; Hotta K; Nakamura N; Zenda S; Motegi A; Ariji T; Hirano Y; Baba H; Ohyoshi H; Nakamura M; Okumura M; Bei Y; Akimoto T
Front Oncol; 2020; 10():517061. PubMed ID: 33194580
[No Abstract] [Full Text] [Related]
12. The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer.
Manning MA; Wu Q; Cardinale RM; Mohan R; Lauve AD; Kavanagh BD; Morris MM; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1400-9. PubMed ID: 11728701
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a mixed beam therapy for postmastectomy breast cancer patients: Bolus electron conformal therapy combined with intensity modulated photon radiotherapy and volumetric modulated photon arc therapy.
Zhang R; Heins D; Sanders M; Guo B; Hogstrom K
Med Phys; 2018 Jul; 45(7):2912-2924. PubMed ID: 29749075
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
[TBL] [Abstract][Full Text] [Related]
15. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
[TBL] [Abstract][Full Text] [Related]
16. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
[TBL] [Abstract][Full Text] [Related]
17. A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity modulated radiotherapy.
Leung WS; Wu VWC; Liu CYW; Cheng ACK
J Appl Clin Med Phys; 2019 Nov; 20(11):121-130. PubMed ID: 31593367
[TBL] [Abstract][Full Text] [Related]
18. Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.
Stokkevåg CH; Indelicato DJ; Herfarth K; Magelssen H; Evensen ME; Ugland M; Nordberg T; Nystad TA; Hægeland C; Alsaker MD; Ulven K; Dale JE; Engeseth GM; Boer CG; Toussaint L; Kornerup JS; Pettersen HES; Brydøy M; Brandal P; Muren LP
Acta Oncol; 2019 Oct; 58(10):1416-1422. PubMed ID: 31364899
[No Abstract] [Full Text] [Related]
19. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X
Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817
[TBL] [Abstract][Full Text] [Related]
20. Beam angle comparison for distal esophageal carcinoma patients treated with intensity-modulated proton therapy.
Feng H; Sio TT; Rule WG; Bhangoo RS; Lara P; Patrick CL; Korte S; Fatyga M; Wong WW; Schild SE; Ashman JB; Liu W
J Appl Clin Med Phys; 2020 Nov; 21(11):141-152. PubMed ID: 33058523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
